Whether lithium inhibits glycogen synthase kinase (GSK)‐3β activity in vivo in humans is still an open question

By  

BIPOLAR DISORDERS (ELECTRONIC), Vol. 18, Iss. 5, 2016-08 ,pp. : 464-467

John Wiley & Sons Inc

Access to resources Recommend Favorite

Signal transducers and activators of transcription 3‐induced metastatic potential in gastric cancer cells is enhanced by glycogen synthase kinase‐3β

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 5, 2015-05 ,pp. : 373-382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Region‐specific dysregulation of glycogen synthase kinase‐3β and β‐catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia

By  

BIPOLAR DISORDERS (ELECTRONIC), Vol. 17, Iss. 2, 2015-03 ,pp. : 160-171

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of Active Fraction of Glycogen Synthase Kinase 3β in Cancer Cells by Nonradioisotopic in vitro Kinase Assay

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 297-305

Karger

Access to resources Recommend Favorite

Glycogen synthase kinase-3β inhibition attenuates the development of ischaemia/reperfusion injury of the gut

By Cuzzocrea Salvatore   Mazzon Emanuela   Esposito Emanuela   Muià Carmelo   Abdelrahman Maha   Paola Rosanna   Crisafulli Concetta   Bramanti Placido   Thiemermann Christoph  

Intensive Care Medicine, Vol. 33, Iss. 5, 2007-05 ,pp. : 880-893

Springer Publishing Company

Access to resources Recommend Favorite